Viewing data from:

LO-ZUMANDIMINE

ANDA

DROSPIRENONE; ETHINYL ESTRADIOL | A209632 | AUROBINDO PHARMA LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: YAZ(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Lo-Zumandimine (2023)

Total Spending

$66K

Total Claims

1,519

Beneficiaries

462

Avg Cost/Unit

$0.88

Spending Trend

$5K(2019)→$29K(2020)→$17K(2021)→$15K(2022)→$66K(2023)

YoY Change:-4.1%

5yr CAGR:-6.1%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 3MG;0.02MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 27, 2018

No patent or exclusivity listings for this strength.